Therapeutic potential of Cinnamomum burmannii bark extract in reducing Malondialdehyde (MDA) levels in MSG-induced wistar rats: a preclinical study

Increased consumption of monosodium glutamate (MSG) is associated with various health risks, including cardiovascular and neurological disorders. MSG triggers an increase in reactive oxygen species (ROS), the end product of lipid peroxidation produced when ROS increases is Malondialdehyde (MDA), On...

Full description

Saved in:
Bibliographic Details
Main Authors: Dina Afrianti, Wahyudi, Ririh Jatmi Wikandari, Rodhi Hartono, Erisa Febriyani, Egy Sunanda Putra
Format: Article
Language:Indonesian
Published: Poltekkes Kemenkes Yogyakarta 2024-12-01
Series:Jurnal Teknologi Laboratorium
Subjects:
Online Access:https://teknolabjournal.com/index.php/Jtl/article/view/497
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841560810915102720
author Dina Afrianti
Wahyudi
Ririh Jatmi Wikandari
Rodhi Hartono
Erisa Febriyani
Egy Sunanda Putra
author_facet Dina Afrianti
Wahyudi
Ririh Jatmi Wikandari
Rodhi Hartono
Erisa Febriyani
Egy Sunanda Putra
author_sort Dina Afrianti
collection DOAJ
description Increased consumption of monosodium glutamate (MSG) is associated with various health risks, including cardiovascular and neurological disorders. MSG triggers an increase in reactive oxygen species (ROS), the end product of lipid peroxidation produced when ROS increases is Malondialdehyde (MDA), On the other hand, interleukin 10 (IL-10) reduces the inflammatory effects in infectious conditions that can cause potential tissue damage. This study investigated the effect of cinnamon bark extract (Cinnamomum burmannii) on MDA and IL-10 levels in MSG-induced Wistar rats. Experiment with Post test only control group design was conducted. The number of samples was 24 male Wistar rats divided into 4 groups. KN healthy rats, K (+) rats were only induced by MSG, P1 rats were induced by MSG and given cinnamon bark extract at a dose of 100 mg, P2 rats were induced by MSG and given cinnamon bark extract at a dose of 200 mg. The average results showed a decrease in MDA levels after 14 days of treatment, one-way ANOVA test p = 0.001 (p <0.05) showed a significant difference in MDA levels KN 2.37 mg/ml ± 0.14, K+ 2.47 mg/ml ± 0.24, P1 2.32 mg/ml ± 0.20, and P2 0.84 mg/ml ± 1.07. Meanwhile, the average IL-10 levels showed no significant difference with one-way Anova test p = 0.127 (p <0.05) in the KN group, IL-10 levels were 93.25 pg / ml ± 25.01, K (+) 112.89 pg / ml ± 43.89, P1 69.48 pg / ml ± 12.83 and P2 93.29 pg / ml ± 12.11. Administration of cinnamon bark extract can reduce MDA levels in rats induced by MSG, but has no significant effect on IL-10 levels.
format Article
id doaj-art-d6ea01c388fc4cc6b0d39a10ebfa9ad2
institution Kabale University
issn 2338-5634
2580-0191
language Indonesian
publishDate 2024-12-01
publisher Poltekkes Kemenkes Yogyakarta
record_format Article
series Jurnal Teknologi Laboratorium
spelling doaj-art-d6ea01c388fc4cc6b0d39a10ebfa9ad22025-01-03T15:40:12ZindPoltekkes Kemenkes YogyakartaJurnal Teknologi Laboratorium2338-56342580-01912024-12-0113211712510.29238/teknolabjournal.v13i2.497449Therapeutic potential of Cinnamomum burmannii bark extract in reducing Malondialdehyde (MDA) levels in MSG-induced wistar rats: a preclinical studyDina Afrianti0Wahyudi1Ririh Jatmi Wikandari2Rodhi Hartono3Erisa Febriyani4Egy Sunanda Putra5Poltekkes Kemenkes SemarangDepartment of Medical Laboratory Technology, Politeknik Kesehatan Kementerian Kesehatan Semarang, Semarang, Central Java, IndonesiaDepartment of Medical Laboratory Technology, Politeknik Kesehatan Kementerian Kesehatan Semarang, Semarang, Central Java, IndonesiaDepartment of Medical Laboratory Technology, Politeknik Kesehatan Kementerian Kesehatan Semarang, Semarang, Central Java, IndonesiaDepartment of Medical Laboratory Technology, Politeknik Kesehatan Kementerian Kesehatan Pelembang Central Java, South Sumatra, IndonesiaDepartement of Health Promotion, Politeknik Kesehatan Kementerian Kesehatan Jambi, Jambi, Indonesia; PUI-PK, Politeknik Kesehatan Kementerian Kesehatan Jambi, Jambi, IndonesiaIncreased consumption of monosodium glutamate (MSG) is associated with various health risks, including cardiovascular and neurological disorders. MSG triggers an increase in reactive oxygen species (ROS), the end product of lipid peroxidation produced when ROS increases is Malondialdehyde (MDA), On the other hand, interleukin 10 (IL-10) reduces the inflammatory effects in infectious conditions that can cause potential tissue damage. This study investigated the effect of cinnamon bark extract (Cinnamomum burmannii) on MDA and IL-10 levels in MSG-induced Wistar rats. Experiment with Post test only control group design was conducted. The number of samples was 24 male Wistar rats divided into 4 groups. KN healthy rats, K (+) rats were only induced by MSG, P1 rats were induced by MSG and given cinnamon bark extract at a dose of 100 mg, P2 rats were induced by MSG and given cinnamon bark extract at a dose of 200 mg. The average results showed a decrease in MDA levels after 14 days of treatment, one-way ANOVA test p = 0.001 (p <0.05) showed a significant difference in MDA levels KN 2.37 mg/ml ± 0.14, K+ 2.47 mg/ml ± 0.24, P1 2.32 mg/ml ± 0.20, and P2 0.84 mg/ml ± 1.07. Meanwhile, the average IL-10 levels showed no significant difference with one-way Anova test p = 0.127 (p <0.05) in the KN group, IL-10 levels were 93.25 pg / ml ± 25.01, K (+) 112.89 pg / ml ± 43.89, P1 69.48 pg / ml ± 12.83 and P2 93.29 pg / ml ± 12.11. Administration of cinnamon bark extract can reduce MDA levels in rats induced by MSG, but has no significant effect on IL-10 levels.https://teknolabjournal.com/index.php/Jtl/article/view/497extract cinnamomum burmannii, mda levels, il-10 levels, msg
spellingShingle Dina Afrianti
Wahyudi
Ririh Jatmi Wikandari
Rodhi Hartono
Erisa Febriyani
Egy Sunanda Putra
Therapeutic potential of Cinnamomum burmannii bark extract in reducing Malondialdehyde (MDA) levels in MSG-induced wistar rats: a preclinical study
Jurnal Teknologi Laboratorium
extract cinnamomum burmannii, mda levels, il-10 levels, msg
title Therapeutic potential of Cinnamomum burmannii bark extract in reducing Malondialdehyde (MDA) levels in MSG-induced wistar rats: a preclinical study
title_full Therapeutic potential of Cinnamomum burmannii bark extract in reducing Malondialdehyde (MDA) levels in MSG-induced wistar rats: a preclinical study
title_fullStr Therapeutic potential of Cinnamomum burmannii bark extract in reducing Malondialdehyde (MDA) levels in MSG-induced wistar rats: a preclinical study
title_full_unstemmed Therapeutic potential of Cinnamomum burmannii bark extract in reducing Malondialdehyde (MDA) levels in MSG-induced wistar rats: a preclinical study
title_short Therapeutic potential of Cinnamomum burmannii bark extract in reducing Malondialdehyde (MDA) levels in MSG-induced wistar rats: a preclinical study
title_sort therapeutic potential of cinnamomum burmannii bark extract in reducing malondialdehyde mda levels in msg induced wistar rats a preclinical study
topic extract cinnamomum burmannii, mda levels, il-10 levels, msg
url https://teknolabjournal.com/index.php/Jtl/article/view/497
work_keys_str_mv AT dinaafrianti therapeuticpotentialofcinnamomumburmanniibarkextractinreducingmalondialdehydemdalevelsinmsginducedwistarratsapreclinicalstudy
AT wahyudi therapeuticpotentialofcinnamomumburmanniibarkextractinreducingmalondialdehydemdalevelsinmsginducedwistarratsapreclinicalstudy
AT ririhjatmiwikandari therapeuticpotentialofcinnamomumburmanniibarkextractinreducingmalondialdehydemdalevelsinmsginducedwistarratsapreclinicalstudy
AT rodhihartono therapeuticpotentialofcinnamomumburmanniibarkextractinreducingmalondialdehydemdalevelsinmsginducedwistarratsapreclinicalstudy
AT erisafebriyani therapeuticpotentialofcinnamomumburmanniibarkextractinreducingmalondialdehydemdalevelsinmsginducedwistarratsapreclinicalstudy
AT egysunandaputra therapeuticpotentialofcinnamomumburmanniibarkextractinreducingmalondialdehydemdalevelsinmsginducedwistarratsapreclinicalstudy